Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy

TH Chen - Therapeutic advances in neurological disorders, 2020 - journals.sagepub.com
Spinal muscular atrophy (SMA), a leading genetic cause of infant death, is a
neurodegenerative disease characterized by the selective loss of particular groups of motor …

[PDF][PDF] Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy

TH Chen - 2020 - researchgate.net
Spinal muscular atrophy (SMA), a leading genetic cause of infant death, is a
neurodegenerative disease characterized by the selective loss of particular groups of motor …

[HTML][HTML] Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy

TH Chen - Therapeutic Advances in Neurological Disorders, 2020 - ncbi.nlm.nih.gov
Spinal muscular atrophy (SMA), a leading genetic cause of infant death, is a
neurodegenerative disease characterized by the selective loss of particular groups of motor …

Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy.

TH Chen - Therapeutic Advances in Neurological Disorders, 2020 - europepmc.org
Spinal muscular atrophy (SMA), a leading genetic cause of infant death, is a
neurodegenerative disease characterized by the selective loss of particular groups of motor …

Circulating microRNAs as potential biomarkers and therapeutic targets in spinal muscular atrophy

TH Chen - Therapeutic advances in neurological …, 2020 - pubmed.ncbi.nlm.nih.gov
Spinal muscular atrophy (SMA), a leading genetic cause of infant death, is a
neurodegenerative disease characterized by the selective loss of particular groups of motor …